NCT07025642 - Comparing Treatments for Overactive Bladder in Taiwan: A Study of Outcomes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

May 1, 2026

Study Completion Date

December 1, 2026

Conditions

Overactive Bladder (OAB)

Interventions

DRUG

Urodynamic evaluation before and after solifenacin treatment.

Cystometry performed at 1 month before and 1, 6 months following/after treatments will be analyzed.

DRUG

Urodynamic evaluation before and after mirabegron treatment.

Cystometry performed at 1 month before and 1, 6 months following/after treatments will be analyzed.

DRUG

Urodynamic evaluation before and after combined treatment with solifenacin and mirabegron.

Cystometry performed at 1 month before and 1, 6 months following/after treatments will be analyzed.

DRUG

Urodynamic evaluation before and after Botulinum toxin (Botox) injection.

Cystometry performed at 1 month before and 1, 6 months following/after treatments will be analyzed.

Trial Locations (1)

RECRUITING

Department of Obstetrics and Gynecology, New Taipei City